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Chlorofluorocarbon Effects on Cardiac, 
Pulmonary, and Respiratory Patients 
ABSTRACT- Research results from studies of the physiological effects of aerosal propellants 
.. on animals and people are summarized. The papers selected for this summary were published 
between 1968 and 1975. Effects of the 15 chlorofluorocarbons used as propellants have been 
recorded on the cardiac, pulmonary and respiratory functions of a number of animal species as 
well as man. The fifteen propellants have been classified into four groups on the basis of 
their degree of toxicity. Fluorocarbon 11, the most frequently used propellant, is in group 1, 
the most toxic. The relative toxicity of each of the 14 other propellants compared with FC 11 
is reported. On the basis of these results, it is suggested that the two problems created by 
chlorofluorocarbon propellants, potential ozone depletion and adverse psychological effects, be 
considered simultaneously, since limiting the exposure would tend to decrease the risk either 
to the ozone layer and to people. 
MILDRED E. OLSON* 
The purpose of this paper is to a) summarize research 
on chlorofluorocarbons used as aerosol propellants, b) 
disseminate this information to enhance awareness of 
the potential for harm to the human body from chloro-
fluorocarbon propellant exposure and c) suggest that 
the two main hazards from these compounds 1) their 
adverse effects on cardiac, pulmonary and respiratory 
function and 2) their potential for diminishing the ozone 
layer around our biosphere be considered simultaneously 
and seriously by decision makers of the world. 
Interest in chlorofluorocarbon propellants is an out-
growth from a personal experience of this author. In 1971, 
I noticed abnormalities in my heart rhythm and in my 
breathing pattern. When I stopped the use of a hair spray, 
these abnormalities disappeared. In attempting to find 
out what there was in hair spray which could produce 
those symptoms, it was not possible to get desired infor-
mation from the label because producers of aerosol pro-
ducts were not required at that time to list the contents. 
I then wrote to the Drug Administration (FDA) in 
Washington, stating: "The possibility exists that I could 
have unique sensitivity to one of the components . . . 
However, my (cardiac and respiratory) symptoms were 
severe enough to have caused considerable concern, and 
I would like to spare others who might be similarly 
unnecessarily affected." The response was that, although 
the product mentionaed had not been analyzed, typical 
sprays contain a Freon propellant , alcohol, and a 
plastic film former. 
"It is possible," the reply noted, "that some indi-
viduals are abnormally sensitive to Freon, however, 
evidence on this point is quite hard to obtain. We are 
sponsoring research in animals on various effects of 
these substances and will take appropriate action if any 
definite hazard appears." 
A personal effort to find out more about Freons 
was made and a search of the literature about their 
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physiological effects, was then undertaken. 
Freons are trade names for that group of chemicals 
which are generically the halogenated hydrocarbons, more 
specifically designated as chlorofluorocarbons. Compounds 
containing fluorine are also called fluoroalkanes. A 
combination lettering and numbering system is sometimes 
used for identification, and the farthest right digit . refers 
to the number of fluorine atoms. FC 12 stands for 
fluorocarbon 12, which is dichlorodifluoromethane. 
Tests on the chlorofluorocarbons in the I 950's 
showed that they were chemically inert and relatively 
non-toxic by the standard tests used. The conclusion 
was that these compounds would be safe to use as 
propellants in spray dispensers. Many chlorofluoro-
carbons are gases which can be liquified at low pressure. 
When an inexpensive release valve was designed , a new 
way for dispersing many compounds became possible . 
· In the I 960's startling and appalling incidents of 
sudden death among healthy young people were attributed 
to inhaling vapors from various produ cts including 
the fluoroalkanes and glues. Abuse of these substances 
was indicated , but the number of deaths was di sturbing 
and suggested that a more thorough evaluation of 
physiological effects was needed . Clinical scient ists 
began sys tematic study of aerosol propellants in the l 970's 
under controlled laboratory conditions. A number of 
investigators suspected that Freon compounds were in 
some way toxic to the heart. 
Death rates among people with asthma also drew 
attention in England and Wales between 1951 and 1964. 
Speizer in ( 1968) demonstrated a three fold increase in 
mortality rates at all ages from 5 to 34, with the 
greatest increase (eight fold) in the 10-14 year age span of 
the asthma group. He suggested that the increase might be 
due to the increased availability of medica lions propelled by 
aerosols. Speizer then studied the records of 177 ast hmatic 
people who had died in Britain and Wales. Although he 
found that 146 of 174 (84 percent) had used aerosol-
dispensed medication , he concluded that the evidence 
from the records was no t sufficient to incriminate aerosol s 
as the cause of death . 
The report of the increased death rate among people 
with asthma stimulated some clinical scientists to study 
the effects of chlorofluorocarbon propellants on lung 
The Minnesuta Academy uf Science 
function. Other investigators were interested in learning 
whether the propellant material was absorbed in the blood. 
Dollery ( 1970) and colleagues were among the first to 
demonstrate that these propellants could be detected in 
the bloodstream after having been inhaled. Paterson and 
co-workers ( 1971) confirmed the preliminary findings of 
Dollery. They measured blood levels of two of the most 
commonly used propellants, Freon 11 and Freon 12, in 
twelve asthmatic patients and three healthy control 
subjects. After the subjects had taken only 2 breaths from 
a dispenser, Paterson found peak Mood levels ranging 
from 0.13 to 2.60 micrograms of FC 11 per milliliter of 
blood. He also determined the time this substance 
remained in the blood, and found that the level of FC 11 
dropped to half the peak level in times ranging from 18 
seconds to 90 seconds. When Paterson could not detect 
FC 12 in the blood, he concluded that this very volatile 
compound must have disappeared before it could be 
measured. 
Taylor- and Harris (1970) found that fluoroalkane 
propellants changed the heart function in mice, dogs, 
and rats. On the 34 mice, the compounds produced 
abnormalities in electrocardiograms and slowed the 
heart rate. They reported that sensitization of the 
heart occurred rapidly, was long-lasting, and fatal. 
These authors were the first to suggest that the effects 
of chlorofluorocarbon propellants would show up in 
different ways in different species, speeding the 
heart rates in some, slowing it in others, and cause 
changes in heart muscle contractility. They pointed 
out that in the earlier toxicity studies investigators 
had not used the electrocardiograph as a monitor, and 
thereby missed detection of cardiac arrhythmia. The 
authors had used the "asphuxia challenge" in their 
experiments and felt that it was important to use this 
to simulate conditions under which the young people 
had died. Alluding to the cases of sudden death among 
young healthy people, Taylor and Harris concluded 
"Since three breaths of propellant sensitize mice immedi-
ately and for hours thereafter to the cardiotoxic 
effects of asphyxia, the amounts of propellant deliberately 
inhaled by these youths seem adequate, particularly 
when combined with asphyxia, to cause fatal cardiac 
toxicity." 
Ors. Flower and Horan ( 1972) studied sixteen dogs 
which they had breathe chlorofluorocarbon propellants. 
They used FC 11 and FC 12 as well as glue. They main-
tained normal arterial oxygen tension with a respirator 
because they wanted to find out whether the heart 
arrhythmias reported by Taylor and Harris when they 
gave an asphyxia challenge to mice were produced or 
made worse by the combination of fluorocarbon plus 
hypoxia. Flowers and Horan recorded electrocardiograms 
and found the same pattern of disturbed heart rhythm 
as were observed by Taylor and Harris. They gave 100 
percent oxygen to six animals. The results were still 
the same--slowing of the heart rate and disturbances of 
the rhythm. 1n some of the experiments, fluorocarbon 
administration was stopped as soon as a change in heart 
rhythm was noted. In spite of this, the animals still 
died. 
Bernstein (1972) focused on the medical hazards of 
aerosols. Reviewing the techniques for studying a 
respiratory problem, he indicated that while inhalation 
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tests can give important information, they should be 
done only under carefully controlled conditions. 
Harris (I 973) summarizing research findings, stated: 
"Contrary to their reputation as being inert, aerosol 
fluoroalkane propellant gases (Freons) are rapidly acting 
and potent cardiac toxins." He indicated that we still 
need to learn how these gases produce their effects on 
the cardiovascular system. He suggested measuring 
blood levels of the chlorofluorocarbons in people who 
frequently use aerosol products. He further suggested 
a study to find out whether people with known diseases 
might be more susceptable or have lower tolerance for 
the toxic effects of the chlorofluorocarbons. When 
his work was criticized by investigators who had been 
unable to demonstra le cardiotoxicity, Harris (1973) pointed 
out that those investigators had not done the same 
kind of experiment that he had done. 
Zuzkin and colleagues (I 974) reported that when they 
exposed 20 healthy subjects, 14 men and six women, to 
three different hair sprays for 20 seconds, they could 
demonstrate a decrease in expiratory flow volume curves. 
This decrease, according to the authors, indicates a 
constriction of the small airways in the lungs. They 
state " ... we believe that our observation should lead 
to increased concern about the respiratory effects of 
hair sprays and other aerosol consumer products." 
Nicholas (I 974) was concerned about the Freon 
propellants used in bronchodilators, observing that these 
compounds were neither inert nor nontoxic. 
Graham ( I 974) expressed his concern about the 
safety of an aerosol product used to speed up the 
process of freezing tissues for microscopic study. 
Speizer (I 975) reported arrhythmias associated with 
fluorocarbon exposure in young doctors in training at the 
pathology department of a hospital. Fluorocarbon 22 
was being used for rapid freezing of tissue specimens. 
Doctors in the second and third year of their training 
(not in the first year) commented on being aware of 
arrhythmias. When exercise electrocardiograms were taken, 
arrhythmias were demonstrated. While arrhythmias 
can occur among otherwise normal people, fewer numbers 
of people not exposed to fluorocarbon propellants in 
that hospital had heart irregularity than the exposed 
personnel. Speizer concluded with a recommendation: 
"From the data presented, we believe that it would 
be prudent for hospital workers using fluorocarbons 
in their work, as well as other industrial groups using 
large quantities of aerosol propellant substances, to 
reassess their needs and seek suitable substitutes." 
Aviado and associates, who in 1974 had published 
some of the results of research, continued in 1975 to 
pulbish results of massive investigations on the effects 
of chlorofluorocarbons. These investigators, on contract 
with the FDA, have collected hard data on the psysio-
logical effects of the 15 chlorofluorocarbons which are 
used as propellants. Different animal species were used 
in order not to miss any important effects these 
compounds might have. On the basis of his data and 
those of other investigators on the effects of the fluoro-
alkane propellants on the pulmonary, respiratory and 
cardiac functions, Aviado has classified the 15 chloro-
fluorocarbons into 4 groups: 
1) - Low pressure propellants of high toxicity. 
According to Aviado, 1trichlorofluoromethane, FC 11, 
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is the most widely used propellant. FC 11 is in this 
group. The other propellants have all been compared 
with FC 11. 
2) - Low pressure propellants of intermediate toxicity. 
3) - High pressure propellants of intermediate toxicity. 
The second most commonly used fluoroalkane pro-
pellant is said to be FC 12. It is in this group. 
4) - High pressure propellants of low toxicity. 
For the compounds in each of the four groups, the 
data have been organized into tables giving the animal 
species and investigator. Each propellant is compared 
with FC 11 with respect to acute inhalational toxicity , 
chronic inhalational toxicity, acute cardiovascular toxicity 
and acute bronchopulmonary toxicity. 
This comparative study by Aviado and colleagues has 
shown the following effects of the fluorocarbons used 
as propellants: 
Inhalations of propellants produces cardiac arrhythmia. 
In some animals, the propellants change heart rate, 
speeding it up in some and slowing it in others, as 
Harris had predicted . In the monkey, all the pro-
pellants except one interfered with the ability of the 
heart muscle to contract. The propellants cause hypo-
tension (lowering of the blood pressure) . They 
produce different breathing patterns - some depressing 
respiration and some stimulating it. They bring about a 
variety of changes in the lung function , depending upon 
the animal. Some dilate the bronchioles in one species 
and constrict the bronchioles in another. Aviado indicates 
that more study of lung function is necessary. 
On the basis of published research results, it is quite 
apparent that the chlorofluorocarbons produce alterations 
in physiological functions of healthy animals and people . 
Aviado warns that since half of the propellants tested 
brought about an increase in pulse rate , exposure to 
any of those would be dangerous to an individual who 
has coronary heart disease. One might add that 
chlorofluorocarbon induced arrhythmias would not be 
helpful to a person with other cardiac problems either. 
Aviado also points out that the effect of the fluoroalkane 
propellants on lung function is important information 
needed for understanding of the possible harm these 
compounds might cause a person whose lung function 
is already decreased by disease or by accident. 
The classification of the fluoroalkanes which Aviado 
has made will be helpful when labeling of aerosols has 
become universal. 
Concern about possible ozone depletion is on the 
increase. Production of chlorofluorocarbons has reached 
800 million pounds per year in this country. Of the 
800 million pounds, 50 percent is used as propellants 
for products packaged in aerosol cans. Total world 
production has rea ched 1. 7 billion pounds (Science 
News). 
With the information from the literature considered 
in this review, it is apparent that we not only need be 
concerned about the possible depletion of the ozone 
layer (by the chlorine released when these compounds are 
broken down) but we also must be concerned about the 
adverse effects the fluorocarbons have been shown to 
have on cardiac, pulmonary and respiratory functions in 
healthy animals and people. We should consider that 
these adverse effects might be even more adverse to 
these functions in people with heart and lung disease. 
By reducing all unnecessary exposure to chloro-
fluorocarbon propellants, we would be removing the 
double jeopardy - je0pardy to the heart and lung 
functions of people and jeopardy to the ozone layer. 
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